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INTRODUCTION
Topically administering vaccines are currently 
being developed because of many bacterial 
and viral pathogens are able to enter the body 
through the skin1). Topical administration has 
the advantage, among others, to avoid the 
first-pass effect in the liver metabolism, pre-
vent degradation in the gastrointestinal tract, 
as well as easier to use and comfortable for the 
patient2). Therefore we need a system that is 
capable of delivering the vaccine to be able to 
penetrate the skin.Microemulsion is a stable 
colloidal dispersion system is thermodynami-
cally and consists of phases of oil, water, sur-
factant, and cosurfactant which forms a clear 
solution with a droplet size of < 200 nm3). 
This system is an ideal system for use as a drug 
delivery has advantages because it is ther-
modynamically stable, ease of manufacturing 
process, has a low viscosity, and droplet sizes 
are very small so that it has a greater surface 
area which facilitates penetration of the active 
compound molecules into the membrane2). 
As a prototype vaccine protein, ovalbumin 
used as an active ingredient. Therefore oval-
bumin dissolved in water, it will be made the 
microemulsion with the type w/o (Water in oil) 
where ovalbumin will be in the water phase 
which trapped by the oil phase. With the mi-
croemulsion type w/o active ingredient will 
be stable. Comparison between the surfactant 
and cosurfactant composition will affect the 
characteristics of the microemulsion system4). 
The characteristics of this system to be a fac-
tor of the release of the active ingredient.The 
aim of this study was to investigate the effects 
of comparison surfactant (Span 80-Tween 80): 
cosurfactant (ethanol) = 5:1, 6:1, and 7:1 in re-
leased of ovalbumin from microemulsion wa-
ter/oil (w/o) system.
METHODS
Material
Ovalbumin (Sigma-Aldrich), soybean oil  food 
grade (PT Pan Pacific Indonesia), Tween 80 
(Croda), Span 80 (Croda), ethanol (Merck), re-
agen Coomassie Brilian Blue (Sigma-Aldrich), 
aquabidest (PT Widatra Bhakti). 
Preparation
Span 80, Tween 80, soybean oil, surfactan 
and cosurfaktan were mixed in different ratio 
(Table 1). In every ratio total concentration 
Surfactant and cosurfactan were 60% . Added 
aquabidest as water phase slowly to form a 
stable water in oil system. Then, mixed Oval-
bumin into the system at high speed.
Table 1. Formula of ovalbumin in W/O microemulsion
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Evaluation
Organoleptic Evaluation
Organoleptic evaluation carried out visually 
includes examining the color, odor, and con-
sistency. The evaluations performed on micro-
emulsion before and after added ovalbumin.
Evaluation Size Distribution of Droplet 
Examination of the size and distribution of the 
microemulsion droplet size was performed 
with a submicron Delsa ™ Nano Particle Size 
and Zeta Potential Dynamic Light Scattering. 
The evaluations performed on microemulsion 
before and after added ovalbumin.
In vitro release studies
The in vitro release of the diclofenac was per-
formed using Franz diffusion Cell with selofan 
as a membran. All in vitro released study were 
performed at 100 rpm, with each medium of 
dissolution (aquabidestilata) was ± 21.5 mL. 
In every 50 µl samples added 2.5 mL reagen 
Coomassie Briliant Blue  at different time in-
tervals were analyzed for drug content using 
spectrophotometer Double Beam UV-VIS Re-
cording UV 18000 (Shimadzu) at a maximum 
wavelength. All of the results were analyzed 
by statistic one way analysis of variance with 
degree of believed 95%. 
RESULT AND DISCUSSION
Organoleptic evaluation of the microemulsion 
before and after added ovalbumin ovalbu-
min in each ratio have the same organoleptic 
which has a distinctive odor, clear yellow color 
and viscous consistency like oil.
In Figure 1 shown the result of the size and 
distribution of the microemulsion droplet 
size showed that the value ± SD from 3 rep-
lications before added ovalbumin in formula 
5:1 was 30.7± 4.01nm; formula 6:1 was 27.6 
± 2.97 nm; and formula 7:1 was 27.1 ± 1.70 
nm. Meanwhile, at the formula that has been 
added ovalbumin has a droplet size in formula 
5:1 was 26.4 ± 0.94nm; formula 6:1 was 23.8 
± 0.26 nm; and formula 7:1 was 25.0 ± 1.14 
nm. The statistical analysis using Independent 
T-Test showed that the value of Tcalculation 
(1,781) < Ttable (2.776) in formula 5:1, Tcalcu-
lation (2.190) < Ttable (2.776) in formula 6:1, 
and  Tcalculation (1.804) < Ttable (2.776) in 
formula 7:1. It means that there was no sig-
nificant difference in each formula before and 
after added ovalbumin.
Figure 1 Histogram of the droplet size in mi-
croemulsion before and after added ovalbu-
min. Each column represents the mean ± SD 
(n=3) 
Figure 2 showed the released process of oval-
bumin  in system microemulsion W/O. Oval-
bumin release was calculated by calculating the 
AUC (Area Under Curve) value of the cumu-
lative amount of ovalbumin released per unit 
area per time. Figure 3 showed the AUC (Area 
Under Curve) of  in vitro ovalbumin released 
study  in system microemulsion W/O each for-
mula. AUC results obtained in the formula 5: 
1 was  4693.46 g /cm2 ± 1764.77,formula 6:1 
was  6590.04 g /cm2 ± 1084.94, and formula 
7: 1 was 5288.90 g /cm2 ± 412.30. The result 
of statistic using ANOVA one way showed that 
Fcalculated (1.898) <  Ftable (5.14). It means 
that there was no significant difference mini-
mum one pair data. Based on these results as 
a whole, with an increase in surfactant-cosur-
factant ratio on formula ratio 5: 1, 6: 1 and 7: 
1 have not been able to provide a statistically 
significant difference from the results of drop-
let size. Therefore, the release of the results 
obtained did not give a significant difference.
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Figure 2. Profile between the amount of oval-
bumin released per unit area (g /cm2) in a va-
riety of formulas versus time
 
Figure 3. Histogram of  AUC the cumulative 
amount of ovalbumin released in each for-
mula. Each column represents the mean ± SD 
(n=3).
CONCLUSION
The released of ovalbumin from microemul-
sion with the comparison of surfactant (Span 
80-Tween 80):  cosurfactant  (ethanol) =5:1, 
6:1, and 7:1) was no significant difference.
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